Experiences after preventive mastectomy for BRCA gene carriers
Part of Cancer, Mental health, Women’s health & pregnancy clinical trials.
This study asks women who carry a BRCA1 or BRCA2 gene change and chose to have their breasts removed to prevent cancer about their experiences after surgery. Participation involves filling out a survey about your feelings and recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older.
- You carry a BRCA1, BRCA2, or related gene change that raises cancer risk.
- You have already had preventive breast removal surgery (risk-reducing mastectomy).
- You are being seen at or have been a patient at the study's clinic.
- You are able to understand the study information, fill out a questionnaire, and agree to take part.
- You cannot take part if you are unable to understand or complete the survey, or if you choose not to consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new way to use your genetic information (along with your family history) to better understand your personal risk for breast cancer. The goal is to see if giving this risk report to women with higher genetic risk can help them and their doctors make more informed decisions about screening and prevention.
This study examines how different molecular subtypes (patterns of genes and proteins) of breast cancer behave in people with BRCA1 or BRCA2 mutations. By studying tumor samples and medical records, researchers hope to better predict which treatments will work best and predict long-term outcomes for BRCA-positive breast cancer patients.
This study follows people who carry a harmful BRCA1 or BRCA2 gene mutation, whether or not they currently have breast or ovarian cancer. The goal is to better understand cancer risk over time and how being a carrier may affect screening and care.
This is an observational study that looks at how different cancer prevention approaches affect women with harmful (deleterious) BRCA1 or BRCA2 mutations. It may help improve future prevention and follow-up plans for women at higher inherited risk.
This study follows women who carry gene mutations that increase ovarian cancer risk to understand how preventive surgery affects their health, quality of life, and peace of mind. Researchers will track your outcomes over 3 years to help inform future treatment decisions for others at similar risk.
This study asks women to complete surveys after learning their genetic risk results for certain breast cancer–related gene changes. It helps researchers understand how people respond and what they think or feel after getting these results.
Hear when a new Heredo Familial Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.